{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:37:50Z","timestamp":1793036270800,"version":"4.5.0"},"reference-count":40,"publisher":"American Association for Cancer Research (AACR)","issue":"22","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Angioimmunoblastic lymphoma (AILT) is the second most common subtype of peripheral T-cell lymphoma (PTCL) and is characterized by dismal prognosis. Thus far, only a few studies have dealt with its molecular pathogenesis. We performed gene expression profile (GEP) analysis of six AILT, six anaplastic large cell lymphomas (ALCL), 28 PTCL-unspecified (PTCL\/U), and 20 samples of normal T lymphocytes (including CD4+, CD8+, and activated and resting subpopulations), aiming to (a) assess the relationship of AILT with other PTCLs, (b) establish the relationship between AILT and normal T-cell subsets, and (c) recognize the cellular programs deregulated in AILT possibly looking for novel potential therapeutic targets. First, we found that AILT and other PTCLs have rather similar GEP, possibly sharing common oncogenic pathways. Second, we found that AILTs are closer to activated CD4+, rather than to resting or CD8+ lymphocytes. Furthermore, we found that the molecular signature of follicular T helper cells was significantly overexpressed in AILT, reinforcing the idea that AILT may arise from such cellular counterpart. Finally, we identified several genes deregulated in AILT, including PDGFRA, REL, and VEGF. The expression of several molecules was then studied by immunohistochemistry on tissue microarrays containing 45 independent AILT cases. Notably, we found that the vascular endothelial growth factor (VEGF) was expressed not only by reactive cells, but also by neoplastic cells, and that nuclear factor-\u03baB (NF-\u03baB) activation is uncommon in AILT, as suggested by frequent exclusively cytoplasmic c-REL localization. Our study provides new relevant information on AILT biology and new candidates for possible therapeutic targets such as PDGFRA (platelet-derived growth factor \u03b1) and VEGF. [Cancer Res 2007;67(22):10703\u201310]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1708","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T15:23:37Z","timestamp":1195140217000},"page":"10703-10710","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":226,"title":["Gene Expression Analysis of Angioimmunoblastic Lymphoma Indicates Derivation from T Follicular Helper Cells and Vascular Endothelial Growth Factor Deregulation"],"prefix":"10.1158","volume":"67","author":[{"given":"Pier Paolo","family":"Piccaluga","sequence":"first","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"},{"name":"2Institute for Cancer Genetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Califano","sequence":"additional","affiliation":[{"name":"3Center for Computational Biology and Biochemistry, Columbia University, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Carbone","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Istituto Nazionale Tumori, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fantoni","sequence":"additional","affiliation":[{"name":"6Division of Experimental Oncology, Centro di Riferimento Oncologico, Aviano, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[{"name":"5Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gazzola","sequence":"additional","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Gloghini","sequence":"additional","affiliation":[{"name":"6Division of Experimental Oncology, Centro di Riferimento Oncologico, Aviano, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Righi","sequence":"additional","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Rossi","sequence":"additional","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tagliafico","sequence":"additional","affiliation":[{"name":"5Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Zupo","sequence":"additional","affiliation":[{"name":"7S.S.D. Diagnostica Malattie Linfoproliferative, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[{"name":"1Institute of Hematology and Medical Oncology \u201cL. and A. Sera\u0300gnoli,\u201d S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"2022061623213972900_B1","unstructured":"Jaffe ES, Ralfkiaer, E. Mature T-cell and NK-cell neoplasms, in Tumours of haematopoietic and lymphoid tissue. Lyon: IARC Press; 2001. p. 189\u2013235."},{"key":"2022061623213972900_B2","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood\u20081994; 84: 1361\u201392.","DOI":"10.1182\/blood.V84.5.1361.bloodjournal8451361"},{"key":"2022061623213972900_B3","doi-asserted-by":"crossref","unstructured":"Jaffe ES. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains. Ann Oncol\u20081995; 6: 631\u20132.","DOI":"10.1093\/oxfordjournals.annonc.a059273"},{"key":"2022061623213972900_B4","doi-asserted-by":"crossref","unstructured":"Ascani S, Zinzani PL, Gherlinzoni F, et al. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol\u20081997; 8: 583\u201392.","DOI":"10.1023\/A:1008200307625"},{"key":"2022061623213972900_B5","unstructured":"Frizzera G, Kaneko Y, Sakurai M. Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions. Leukemia\u20081989; 3: 1\u20135."},{"key":"2022061623213972900_B6","doi-asserted-by":"crossref","unstructured":"Nakamura S, Suchi T. A clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma. Angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer\u20081991; 67: 2566\u201378.","DOI":"10.1002\/1097-0142(19910515)67:10<2565::AID-CNCR2820671029>3.0.CO;2-4"},{"key":"2022061623213972900_B7","doi-asserted-by":"crossref","unstructured":"Jaffe ES. Pathobiology of peripheral T-cell lymphomas. Hematol Am Soc Hematol Educ Program 2006;317\u201322.","DOI":"10.1182\/asheducation-2006.1.317"},{"key":"2022061623213972900_B8","doi-asserted-by":"crossref","unstructured":"Went P, Agostinelli C, Gallamini A, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol\u20082006; 24: 2472\u20139.","DOI":"10.1200\/JCO.2005.03.6327"},{"key":"2022061623213972900_B9","doi-asserted-by":"crossref","unstructured":"Krenacs L, Schaerli P, Kis G, Bagdi E. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood\u20082006; 108: 1110\u20131.","DOI":"10.1182\/blood-2006-01-0394"},{"key":"2022061623213972900_B10","doi-asserted-by":"crossref","unstructured":"Grogg KL, Attygale AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol\u20082006; 19: 1101\u20137.","DOI":"10.1038\/modpathol.3800625"},{"key":"2022061623213972900_B11","doi-asserted-by":"crossref","unstructured":"Dupuis J, Boye K, Martin N, et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol\u20082006; 30: 490\u20134.","DOI":"10.1097\/00000478-200604000-00009"},{"key":"2022061623213972900_B12","doi-asserted-by":"crossref","unstructured":"Lepretre S, Buchonnet G, Stamatoullas A, et al. Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet\u20082000; 117: 71\u20139.","DOI":"10.1016\/S0165-4608(99)00151-X"},{"key":"2022061623213972900_B13","doi-asserted-by":"crossref","unstructured":"Martinez-Delgado B, Melendez B, Cuadros M, et al. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res\u20082004; 10: 4971\u201382.","DOI":"10.1158\/1078-0432.CCR-04-0269"},{"key":"2022061623213972900_B14","doi-asserted-by":"crossref","unstructured":"Mahadevan D, Spier C, Della Croce K, et al. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Mol Cancer Ther\u20082005; 4: 1867\u201379.","DOI":"10.1158\/1535-7163.MCT-05-0146"},{"key":"2022061623213972900_B15","doi-asserted-by":"crossref","unstructured":"Ballester B, Ramuz O, Gisselbrecht C, et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene\u20082006; 25: 1560\u201370.","DOI":"10.1038\/sj.onc.1209178"},{"key":"2022061623213972900_B16","doi-asserted-by":"crossref","unstructured":"de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood\u20082007; 109: 4952\u201363.","DOI":"10.1182\/blood-2006-10-055145"},{"key":"2022061623213972900_B17","doi-asserted-by":"crossref","unstructured":"Piccaluga PP, Agostinelli C, Califano A, et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest\u20082007; 117: 823\u201334.","DOI":"10.1172\/JCI26833"},{"key":"2022061623213972900_B18","doi-asserted-by":"crossref","unstructured":"Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells. J Immunol\u20082004; 173: 68\u201378.","DOI":"10.4049\/jimmunol.173.1.68"},{"key":"2022061623213972900_B19","doi-asserted-by":"crossref","unstructured":"Chtanova T, Newton R, Liu SM, et al. Identification of T cell\u2013restricted genes, and signatures for different T cell responses, using a comprehensive collection of microarray datasets. J Immunol\u20082005; 175: 7837\u201347.","DOI":"10.4049\/jimmunol.175.12.7837"},{"key":"2022061623213972900_B20","doi-asserted-by":"crossref","unstructured":"Hosack DA, Dennis G, Jr., Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol\u20082003; 4: R70.","DOI":"10.1186\/gb-2003-4-6-p4"},{"key":"2022061623213972900_B21","doi-asserted-by":"crossref","unstructured":"Sado Y, Kagawa M, Naito I, et al. Organization and expression of basement membrane collagen IV genes and their roles in human disorders. J Biochem (Tokyo)\u20081998; 123: 767\u201376.","DOI":"10.1093\/oxfordjournals.jbchem.a022003"},{"key":"2022061623213972900_B22","doi-asserted-by":"crossref","unstructured":"van den Boom J, Wolter M, Kuick R, et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol\u20082003; 163: 1033\u201343.","DOI":"10.1016\/S0002-9440(10)63463-3"},{"key":"2022061623213972900_B23","doi-asserted-by":"crossref","unstructured":"Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev\u20082006; 25: 9\u201334.","DOI":"10.1007\/s10555-006-7886-9"},{"key":"2022061623213972900_B24","doi-asserted-by":"crossref","unstructured":"Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev\u20081999; 79: 1283\u2013316.","DOI":"10.1152\/physrev.1999.79.4.1283"},{"key":"2022061623213972900_B25","doi-asserted-by":"crossref","unstructured":"Pardanani A, Tefferi A. Imatinib targets other than bcr\/abl and their clinical relevance in myeloid disorders. Blood\u20082004; 104: 1931\u20139.","DOI":"10.1182\/blood-2004-01-0246"},{"key":"2022061623213972900_B26","doi-asserted-by":"crossref","unstructured":"Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev\u20082004; 4: 11\u201322.","DOI":"10.1038\/nrc1252"},{"key":"2022061623213972900_B27","doi-asserted-by":"crossref","unstructured":"Jin S, Tong T, Fan W, et al. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene\u20082002; 21: 8696\u2013704.","DOI":"10.1038\/sj.onc.1206034"},{"key":"2022061623213972900_B28","doi-asserted-by":"crossref","unstructured":"Papa S, Zazzeroni F, Bubici C, et al. Gadd45-\u03b2 mediates the NF-\u03baB suppression of JNK signalling by targeting MKK7\/JNKK2. Nat Cell Biol\u20082004; 6: 146\u201353.","DOI":"10.1038\/ncb1093"},{"key":"2022061623213972900_B29","doi-asserted-by":"crossref","unstructured":"Chen F, Lu Y, Zhang Z, et al. Opposite effect of NF-\u03baB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem\u20082001; 276: 11414\u20139.","DOI":"10.1074\/jbc.M011682200"},{"key":"2022061623213972900_B30","doi-asserted-by":"crossref","unstructured":"Hirose T, Sowa Y, Takahashi S, et al. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene\u20082003; 22: 7762\u201373.","DOI":"10.1038\/sj.onc.1207091"},{"key":"2022061623213972900_B31","doi-asserted-by":"crossref","unstructured":"Piekarz RL, Robey R, Sandor V, et al. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood\u20082001; 98: 2865\u20138.","DOI":"10.1182\/blood.V98.9.2865"},{"key":"2022061623213972900_B32","doi-asserted-by":"crossref","unstructured":"Piccaluga PP, Agostinelli C, Zinzani PL, Baccarani M, Dalla Favera R, Pileri SA. Expression of platelet-derived growth factor receptor \u03b1 in peripheral T-cell lymphoma not otherwise specified. Lancet Oncol\u20082005; 6: 440.","DOI":"10.1016\/S1470-2045(05)70213-8"},{"key":"2022061623213972900_B33","doi-asserted-by":"crossref","unstructured":"Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood\u20082005; 106: 1501\u20132.","DOI":"10.1182\/blood-2005-03-1083"},{"key":"2022061623213972900_B34","doi-asserted-by":"crossref","unstructured":"Zhao WL, Mourah S, Mounier N, et al. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest\u20082004; 84: 1512\u20139.","DOI":"10.1038\/labinvest.3700145"},{"key":"2022061623213972900_B35","doi-asserted-by":"crossref","unstructured":"Martinez-Delgado B, Cuadros M, Honrado E, et al. Differential expression of NF-\u03baB pathway genes among peripheral T-cell lymphomas. Leukemia\u20082005; 19: 2254\u201363.","DOI":"10.1038\/sj.leu.2403960"},{"key":"2022061623213972900_B36","doi-asserted-by":"crossref","unstructured":"Geissinger E, Bonzheim I, Krenacs L, et al. Nodal peripheral T-cell lymphomas correspond to distinct mature T-cell populations. J Pathol\u20082006; 210: 172\u201380.","DOI":"10.1002\/path.2046"},{"key":"2022061623213972900_B37","doi-asserted-by":"crossref","unstructured":"Strupp C, Aivado M, Germing U, Gattermann N, Haas R. Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports. Leuk Lymphoma\u20082002; 43: 133\u20137.","DOI":"10.1080\/10428190210190"},{"key":"2022061623213972900_B38","doi-asserted-by":"crossref","unstructured":"Dogan A, Ngu LS, Ng SH, Cervi PL. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia\u20082005; 19: 873\u20135.","DOI":"10.1038\/sj.leu.2403710"},{"key":"2022061623213972900_B39","unstructured":"Ramasamy K, Lim Z, Pagliuca A, Salisbury JR, Mufti GJ, Devereux S. Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone. Haematologica\u20082006; 91: ECR44."},{"key":"2022061623213972900_B40","doi-asserted-by":"crossref","unstructured":"Bruns I, Fox F, Reinecke P, et al. Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab. Leukemia\u20082005; 19: 1993\u20135.","DOI":"10.1038\/sj.leu.2403936"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/22\/10703\/2574854\/10703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/22\/10703\/2574854\/10703.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:55:29Z","timestamp":1655420129000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/22\/10703\/533657\/Gene-Expression-Analysis-of-Angioimmunoblastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":40,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2007,11,15]]},"published-print":{"date-parts":[[2007,11,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1708","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496316","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496316.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370225.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370222","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370225","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370222.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,15]]}}}